This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Universitéde Strasbourg. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Hugues Greney: Innovator in Metabolic Syndrome Treatment
Introduction
Hugues Greney is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmacology, particularly in the development of novel compounds aimed at addressing metabolic syndrome. His work is characterized by a commitment to innovation and scientific advancement.
Latest Patents
Hugues Greney holds a patent for "Amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome." This patent encompasses novel amino-pyrrolinic derivatives, their pharmacologically acceptable salts, and their application in preventing and treating metabolic syndrome. His innovative approach has the potential to impact the health and well-being of many individuals affected by this condition.
Career Highlights
Greney is affiliated with the Université de Strasbourg, where he has been involved in research and development activities. His academic background and research endeavors have positioned him as a key figure in his field. His dedication to advancing medical science is evident through his patent and ongoing research efforts.
Collaborations
Hugues Greney has collaborated with esteemed colleagues, including Vincent Gasparik and Lyne Fellmann. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Hugues Greney's contributions to the field of metabolic syndrome treatment through his innovative patent highlight his role as a leading inventor. His work at the Université de Strasbourg and collaborations with fellow researchers underscore his commitment to advancing medical science.